Assessment of Protective Properties of Optimized Flagellin Derivative Against Biologically Harmful Effects of Ionizing Irradiation During Space Flight
Award amount
$99,589Program and phase
STTR · Phase IAward year
2006Award details
- Awarding agency
- National Aeronautics and Space Administration
- Branch
- Not reported
- Recipient company
- Cleveland Biolabs, Inc
- Proposal award date
- 2006-01-24
- Contract end date
- 2007-01-22
- UEI
- J223MEGF2LP1
- Solicitation number
- Not reported
- Topic code
- T1.02
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- RADIOPROTECTORS TARGETING P53
- N-myc Targeted Therapeutics for Childhood Neuroblastoma
- RADIOPROTECTORS TARGETING P53
- Effective Radioprotectants Targeting Toll-like Receptor 5
- Bacterial Proteins as Cancer Drugs and Radioprotectors
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Transient Acoustic Environment Prediction Tool for Launch Vehicles in Motion during Early Lift-Off
- Multiphase Modeling of Solid Rocket Motor Internal Environment
- Multiphysics Framework for Prediction of Dynamic Instability in Liquid Rocket Engines
- A Massively Parallel Framework for Low-Dissipation, Multiphysics Simulations of Rocket Engines
- High Performance Simulation Tool for Multiphysics Propulsion Using Fidelity-Adaptive Combustion Modeling
Research funding history
11 SBIR/STTR records share this UEI (2004–2007). Reported award amounts total $2,269,549. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Aeronautics and Space Administration